Abstract
Samples from 19 resected lung tumours have been analysed for the levels of GST α, μ and π mRNA and protein. No significant survival disadvantage was found for patients with tumours containing any of the GST subtypes at the levels of either protein or mRNA. Both GST μ and GST π mRNAs were expressed at significantly higher levels in squamous carcinomas than adenocarcinomas but GST α mRNA was not. The significant increases in expression of μ and π GST in squamous relative to adenocarcinomas of the lung is not related to differences in the proliferation rates between these cancers.
| Original language | English |
|---|---|
| Pages (from-to) | 881-886 |
| Number of pages | 6 |
| Journal | International Journal of Oncology |
| Volume | 3 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 1 Jan 1993 |